I agree that this site is using cookies. You can find further informations here.
X
Yarur, Andres J
210  results:
Search for persons X
?
1

Su1821 THE ASSOCIATION BETWEEN 6-THIOGUANINE NUCLEOTIDE LEV..:

Yarur, Andres ; Abraham, Bincy P. ; Conklin, John...
Gastroenterology.  166 (2024)  5 - p. S-829 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Su1766 OZANIMOD IS MORE EFFECTIVE IN ADVANCED THERAPY–NAIVE..:

Colombel, Jean Frederic ; Hanauer, Stephen B. ; Yarur, Andres...
Gastroenterology.  166 (2024)  5 - p. S-803-S-804 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Tu1772 PRE-OPERATIVE VISCERAL ADIPOSE TISSUE (VAT)-BASED RA..:

Gu, Phillip ; Dube, Shishir ; Lee, Yoo Jin...
Gastroenterology.  166 (2024)  5 - p. S-1415 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Sa1027 PROACTIVE PATIENT ENGAGEMENT TO PROMOTE REPRESENTATI..:

Rubin, David T. ; Yarur, Andres ; Garrett, Leigh...
Gastroenterology.  166 (2024)  5 - p. S-325-S-326 , 2024
Link: https://doi.org/10.1016/..
 
?
5

ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dos..:

Jairath, Vipul ; Yarur, Andres ; Osterman, Mark T....
Clinical Gastroenterology and Hepatology.  22 (2024)  5 - p. 1077-1086.e13 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Su1828 PRECISION DOSING TEST FOR OPTIMIZING ADALIMUMAB IN I..:

Hanauer, Stephen B. ; Torres, Esther A. ; Swaminath, Arun...
Gastroenterology.  166 (2024)  5 - p. S-832 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Su1797 ETRASIMOD SHOWS LOW RISK OF ADVERSE EVENTS FOLLOWING..:

Afzali, Anita ; Regueiro, Miguel D. ; Yarur, Andres J....
Gastroenterology.  166 (2024)  5 - p. S-818 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Su1756 UPADACITINIB IMPROVES CLINICAL AND ENDOSCOPIC OUTCOM..:

Yarur, Andres ; Abreu, Maria T. ; Colombel, Jean Frederic...
Gastroenterology.  166 (2024)  5 - p. S-799 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Tu1882 REAL-WORLD EFFECTIVENESS AND SAFETY OF UPADACITINIB ..:

Devi, Jalpa ; Chowla, Navreet M. ; Khan, Abdul...
Gastroenterology.  166 (2024)  5 - p. S-1452 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Su1803 HIGHER MAINTENANCE ADALIMUMAB CONCENTRATION IS ASSOC..:

Papamichail, Konstantinos ; Centritto, Andrea ; Guillo, Lucas...
Gastroenterology.  166 (2024)  5 - p. S-821 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Efficacy and Safety of Etrasimod in Patients with Moderatel..:

Peyrin-Biroulet, Laurent ; Dubinsky, Marla C ; Sands, Bruce E...
Journal of Crohn's and Colitis.  , 2024
Link: https://doi.org/10.1093/..
 
?
12

Predictive Factors of Non-Inflammatory Small Bowel Obstruct..:

Zulqarnain, Mir ; Jaber, Fouad ; Jahagirdar, Vinay...
Gastroenterology Research.  17 (2024)  2 - p. 64-71 , 2024
Link: https://doi.org/10.14740..
 
?
13

Tu1889 REAL-WORLD EFFECTIVENESS AND SAFETY OF OZANIMOD IN U..:

Lieto, Stephen ; Scalzo, Nicholas ; Huang, Katherine...
Gastroenterology.  166 (2024)  5 - p. S-1455-S-1456 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Etrasimod for the Treatment of Ulcerative Colitis: Analysis..:

Regueiro, Miguel ; Siegmund, Britta ; Yarur, Andres J...
Journal of Crohn's and Colitis.  , 2024
Link: https://doi.org/10.1093/..
 
?
15

Su1765 IMPACT OF IMMUNOGENICITY ON CLINICAL OUTCOMES IN PAT..:

Colombel, Jean Frederic ; Danese, Silvio ; Schreiber, Stefan...
Gastroenterology.  166 (2024)  5 - p. S-803 , 2024
Link: https://doi.org/10.1016/..
 
1-15